Earnings History Data for Global Blood Therapeutics, Inc. (GBT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Global Blood Therapeutics, Inc.

Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which is in clinical trial. The company in addition to GBT is involved in research and development activities targeted hypoxemic pulmonary disorders, including idiopathic pulmonary fibrosis and hereditary angioedema. Global Blood Therapeutics, Inc. is based in South San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
04-11-2021 AH 4:05 PM ET
(Nov 4)
GBT Global Blood Therapeutics, Inc. 2,430 -1.13 -1.10 -0.97 Global Blood Therapeutics EPS misses by $0.02, misses on revenue
[11/4/2021 4:27 PM]
35.19 -4.18 
(-10.62%)
35.00 -4.37 
(-11.10%)
25.11 - 62.73 2,707,610 1,440,000 61,150
03-08-2021 AH 4:05 PM ET
(Aug 3)
GBT Global Blood Therapeutics, Inc. 1,700 -1.12 -1.17 -0.86 Global Blood Therapeutics EPS beats by $0.07, beats on revenue
[8/3/2021 4:14 PM]
32.28 5.39 
(20.04%)
31.80 4.91 
(18.26%)
26.15 - 70.43 3,645,428 1,110,000 72,347
05-05-2021 AH 4:05 PM ET
(May 5)
GBT Global Blood Therapeutics, Inc. 2,530 -1.21 -1.02 -1.20 Global Blood Therapeutics EPS misses by $0.20, misses on revenue
[5/5/2021 4:17 PM]
38.23 -1.60 
(-4.02%)
38.23 0.0 
(0.00%)
36.01 - 83.69 2,479,877 730,000 20,168
24-02-2021 AH 4:05 PM ET
(Feb 24)
GBT Global Blood Therapeutics, Inc. 3,000 -1.00 -0.97 -1.73 Global Blood Therapeutics EPS misses by $0.04, beats on revenue
[2/24/2021 4:15 PM]
43.86 -5.32 
(-10.83%)
44.81 -4.38 
(-8.90%)
36.49 - 83.69 3,562,015 917,764 18,568
05-11-2020 AH 4:00 PM ET
(Nov 5)
GBT Global Blood Therapeutics, Inc. 3,310 -0.97 -0.72 -1.07 Global Blood Therapeutics EPS misses by $0.25, misses on revenue
[11/5/2020 4:39 PM]
38.26 -22.06 
(-36.57%)
40.19 -20.13 
(-33.37%)
37.50 - 87.54 13,758,634 1,011,662 404,474
05-08-2020 AH 4:05 PM ET
(Aug 5)
GBT Global Blood Therapeutics, Inc. 4,110 -0.86 -1.18 -1.01 Global Blood Therapeutics EPS beats by $0.29, beats on revenue
[8/5/2020 4:15 PM]
65.27 -2.63 
(-3.87%)
69.40 1.50 
(2.21%)
39.95 - 87.54 819,665 551,335 4,236
06-05-2020 AH GBT Global Blood Therapeutics, Inc. 4,730 -1.20 -1.47 -0.87 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0